YI - PRICE - 111, Inc.

111, Inc. (YI) operates a leading Chinese B2B pharmaceutical marketplace, integrating cloud accounting services into the operations of thousands of pharmacies. Large-scale logistics create insurmountable barriers to entry, although government price controls limit profitability, which stands at 3.61. Historical price action clearly demonstrates the asset's market trends. The company is also developing a healthcare ecosystem, uniting insurance operators and the largest drug manufacturers to optimize delivery.

For 111, Inc. (YI), the price action reflects the market value of its share in China's digital pharmaceutical ecosystem, where the network effect between pharmacies and suppliers drives capitalization. This chart captures closing session quotes, allowing investors to assess the asset's sensitivity to industry cycles and identify points of overvaluation relative to the business's fundamental stability.